On Tuesday, Cardiff Oncology Inc (NASDAQ: CRDF) was -4.85% drop from the session before settling in for the closing price of $2.68. A 52-week range
On Tuesday, Cardiff Oncology Inc (NASDAQ: CRDF) was -5.76% drop from the session before settling in for the closing price of $2.95. A 52-week range
Cardiff Oncology Inc (NASDAQ: CRDF) started the day on Wednesday, with a price decrease of -3.61% at $2.94, before settling in for the price of
On Thursday, Cardiff Oncology Inc (NASDAQ: CRDF) remained unchanged from the previous day of trading 1.42% from the last session, before settling in for the
Witnessing the stock’s movement on the chart, on Wednesday, Cardiff Oncology Inc (NASDAQ: CRDF) had a quiet start as it plunged -4.42% to $2.81, before
A new trading day began on Friday, with Cardiff Oncology Inc (NASDAQ: CRDF) stock price up 3.78% from the previous day of trading, before settling
Cardiff Oncology Inc (NASDAQ: CRDF) on Tuesday, plunged -5.20% from the previous trading day, before settling in for the closing price of $2.69. Within the
Witnessing the stock’s movement on the chart, on Wednesday, Cardiff Oncology Inc (NASDAQ: CRDF) had a quiet start as it plunged -1.63% to $3.01, before
Cardiff Oncology Inc (NASDAQ: CRDF) on Friday, plunged -4.36% from the previous trading day, before settling in for the closing price of $3.44. Within the
Cardiff Oncology Inc (NASDAQ: CRDF) open the trading on Wednesday, with a bit cautious approach as it glided -6.84% to $3.54, before settling in for
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
